We studied 142 consecutive ASC pts. (91 diabetic) admitted to the CCU at NWAFH. Including UA, NSTEMI and STEMI.
Diabetics were older (61 vs 51 y) [<em>pem> < 0.001], with higher BMI (30 vs 28) [<em>pem> < 0.05], hypertension (71 % vs 31 % ) [<em>pem> < 0.001], hyperlipedemia (54 % vs 28 % ) [<em>pem> < 0.001] and history of IHD (58 % vs 39 % ) [<em>pem> < 0.05]. There was no significant difference in mode of presentation between diabetics and non-diabetics, NSTEMI/UA (62 % vs 43 % ) and STEMI (36 % vs 47 % ) [PNS for both] or KILLIP class at admission. EF by 2D-echo was similar in both groups (37 ¡À 12 % vs 40 ¡À 13 % ) [PNS]. Pre-admission medications were more frequently prescribed to the diabetics, asprin (75 % vs 57 % ), clopidogrel (46 % vs 24 % ) [<em>pem> < 0.05] for both. Beta-blockers (56 % vs 28 % ) [<em>pem> = 0.001] and ACEi/ARBs (73 % vs 49 % ) [<em>pem> < 0.001]. Coronary angiography was offered equally to both groups (64 % vs 63 % ), while there was trend for more prevalence of multi-vessel disease (MVD) in diabetics (29 % vs 20 % ) [PNS]. As well as trend for more hospital mortality rate in diabetics (6.6 % vs 2 % ) [PNS].
Compared to non-diabetics ACS at NWAFH, diabetics are older, with more of hypertension, BMI, hyperlipedemia and IHD history. They were more frequently prescribed pre-admission medications. No impact of diabetes on mode of presentation (STEMI vs NSTEMI/UA) was found. Invasive approach is equally offered to both groups, with a trend for more prevalence of MVD and hospital mortality in the diabetic patients.